ArticleBioImpacts : BI2013

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

Seyed Moein Moghimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.